Clinical Trial

Ashwagandha for Nighttime Waking

Completed
View on ClinicalTrials.gov →
Summary
The purpose of this research is to evaluate the effect of a sustained-release, lower-dosage (150mg) Ashwagandha supplement to reduce disturbed sleep. 54 participants, after randomization, will take either an Ashwagandha supplement or a placebo daily for 28 days (week 4) and wear an Oura ring. The Oura ring will measure waking after sleep onset (WASO). Questionnaires to evaluate quality of life and sleep will be administered at baseline and week 4.
Protocol Amendment History 1 change
critical Trial completed 2026-06-18
Trial Details
NCT Number NCT07151261
Lead Sponsor National University of Natural Medicine
Conditions Disturbed Sleep
Enrollment 54 participants
Start Date 2025-10-20
Primary Completion 2026-05-05 (estimated)
Study Completion 2026-05-05 (estimated)
Updated on ClinicalTrials.gov 2026-06-17